Exponent Inc. (NASDAQ:EXPO) was upgraded by Zacks Investment Research from a “strong sell” rating to a “hold” rating in a research note issued on Tuesday.
According to Zacks, “Exponent, Inc., is a multidisciplinary organization of scientists, physicians, engineers and business consultants performing in-depth scientific research and analysis in over 90 technical disciplines. The company is an engineering and scientific consulting firm providing solutions to complex problems. The firm has been best known for analyzing accidents and failures to determine their causes, but in recent years it has become more active in assisting clients with human health, environmental and engineering issues associated with new products to help prevent problems in the future. The Company serves clients in the automotive, aviation, chemical, construction, consumer products, energy, government, health, insurance, manufacturing, technology and other sectors. “
Other research analysts also recently issued reports about the stock. Cantor Fitzgerald initiated coverage on shares of Exponent in a research note on Friday, August 26th. They set a “buy” rating and a $57.00 price objective on the stock. Avondale Partners initiated coverage on shares of Exponent in a research note on Thursday, July 7th. They set a “market perform” rating and a $60.00 price objective on the stock.
Shares of Exponent (NASDAQ:EXPO) opened at 50.51 on Tuesday. The company’s 50-day moving average is $50.45 and its 200-day moving average is $51.79. Exponent has a 12-month low of $43.27 and a 12-month high of $59.71. The stock has a market cap of $1.31 billion, a P/E ratio of 28.86 and a beta of 0.81.
Exponent (NASDAQ:EXPO) last posted its quarterly earnings data on Tuesday, July 19th. The company reported $0.38 EPS for the quarter, missing the Zacks’ consensus estimate of $0.43 by $0.05. Exponent had a net margin of 15.13% and a return on equity of 16.02%. The company had revenue of $77.30 million for the quarter, compared to the consensus estimate of $80.46 million. On average, analysts expect that Exponent will post $1.59 earnings per share for the current fiscal year.
The firm also recently announced a quarterly dividend, which will be paid on Friday, September 23rd. Shareholders of record on Friday, September 2nd will be issued a dividend of $0.18 per share. The ex-dividend date is Wednesday, August 31st. This represents a $0.72 dividend on an annualized basis and a dividend yield of 1.43%. Exponent’s dividend payout ratio (DPR) is 41.62%.
In other Exponent news, CEO Paul R. Johnston sold 5,500 shares of the stock in a transaction on Monday, June 27th. The shares were sold at an average price of $54.74, for a total transaction of $301,070.00. Following the sale, the chief executive officer now directly owns 75,536 shares of the company’s stock, valued at $4,134,840.64. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CEO Paul R. Johnston sold 5,578 shares of the stock in a transaction on Friday, July 8th. The stock was sold at an average price of $58.15, for a total transaction of $324,360.70. Following the sale, the chief executive officer now directly owns 64,458 shares in the company, valued at $3,748,232.70. The disclosure for this sale can be found here. Company insiders own 3.50% of the company’s stock.
Several hedge funds have recently modified their holdings of EXPO. Advisor Group Inc. acquired a new stake in shares of Exponent during the second quarter worth $107,000. Tower Research Capital LLC TRC purchased a new stake in Exponent during the second quarter worth $121,000. Victory Capital Management Inc. boosted its stake in Exponent by 77.2% in the second quarter. Victory Capital Management Inc. now owns 2,442 shares of the company’s stock worth $143,000 after buying an additional 1,064 shares during the period. Advisory Services Network LLC boosted its stake in Exponent by 2.2% in the second quarter. Advisory Services Network LLC now owns 2,781 shares of the company’s stock worth $162,000 after buying an additional 59 shares during the period. Finally, PineBridge Investments L.P. boosted its stake in Exponent by 4.8% in the second quarter. PineBridge Investments L.P. now owns 3,292 shares of the company’s stock worth $192,000 after buying an additional 150 shares during the period. 91.46% of the stock is currently owned by institutional investors.
Exponent, Inc, along with its subsidiaries, is a science and engineering consulting company. The Company operates through two segments: Engineering and Other Scientific, and Environmental and Health. Its Engineering and Other Scientific segment includes biomechanics, biomedical engineering, buildings and structures, civil engineering, construction consulting, electrical engineering and computer science, engineering management consulting, human factors, industrial structures, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, technology development, thermal sciences and vehicle analysis services.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Exponent Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Exponent Inc. and related companies with MarketBeat.com's FREE daily email newsletter.